ArticleCureus2026
Monitoring Real-World Function With an Oura Ring Following Bilateral Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Subthalamic nucleus deep brain stimulation (STN DBS) is a well-established therapy for Parkinson's disease (PD), but conventional follow-up may miss postoperative fluctuations. Consumer-grade wearable devices present a scalable, low-burden means of longitudinal monitoring outside the clinic. We report a single-patient case of a 68-year-old man with PD who continuously wore an Oura Ring before and after STN DBS. Proprietary composite "Activity", "Readiness", and "Sleep" scores were analysed descriptively across predefined 60-day pre- and post-DBS periods, excluding the immediate perioperative period. Longer-term trends were assessed over 12 months alongside clinical outcomes. Early post-DBS, "Sleep Score" improved from 45.0 to 53.5 and "Readiness Score" from 67.5 to 71.0, while "Activity Score" and daily step count remained stable despite improvement in the Movement Disorder Society-Unified Parkinson's Disease Rating Scale Part III score. This divergence suggested that clinic-based motor improvement did not translate into increased free-living activity. "Sleep" and "Readiness" scores remained higher during later follow-up following DBS optimisation, broadly coinciding with improvements in sleep and quality-of-life measures. This case illustrates how wearable-derived data may complement conventional postoperative assessments by capturing longitudinal patterns not routinely measured in follow-up. Larger studies are required to determine whether such consumer-grade measures can be interpreted as clinically useful digital biomarkers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.